gene_symbol
BCL2
hgnc_id
HGNC:990
binding_type
other
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Venetoclax directly inhibits BCL-2, releasing pro-apoptotic effectors (BAX/BAK) to cause mitochondrial outer membrane permeabilization, cytochrome c release, caspase activation, and apoptosis of BCL-2-dependent cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
BH3 mimetic binding to the BH3-binding hydrophobic groove
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06150040
disease_id_num_tar_ref
5892
drug_id_num_tar_ref
15987